Tag - daiichi-sankyo

 
Menu
Search
 
January 22, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

DAIICHI SANKYO

The U.S. Food and Drug Administration's approval of novel breast cancer treatment by Daiichi Sankyo and AstraZeneca led Daiichi Sankyo's shares to post the largest intraday gain since August on Monday.
BUSINESS / Companies
Jan 20, 2025
Daiichi Sankyo rises most in five months on cancer drug approval
Datroway, developed with AstraZeneca, has been approved for patients with advanced breast tumors.
Daiichi Sankyo's headquarters in Tokyo
BUSINESS
Jan 18, 2025
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
Keisuke Yoshida, a former Daiichi Sankyo employee, was sentenced to 16 years in prison on Wednesday for murdering his wife with methanol in 2022.
JAPAN / Crime & Legal
Oct 31, 2024
Ex-employee of drugmaker sentenced to 16 years for methanol murder
Tokyo District Court on Wednesday sentenced a former employee of drugmaker Daiichi Sankyo to 16 years in prison for the murder of his wife by methanol poisoning in 2022.
The Tokyo District Court
JAPAN / Crime & Legal
Oct 11, 2024
Ex-Daiichi Sankyo employee faces 18 years for allegedly poisoning wife
The indictment states that Keisuke Yoshida intentionally poisoned his 40-year-old wife, Yoko, by having her ingest methanol at their home in Tokyo.
Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
Daiichi Sankyo is working on the next generation of targeted cancer drugs.
JAPAN / Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi’s continued success, with its share price up 122% in the last five years.
Keisuke Yoshida, 42, is accused of killing his wife by poisoning her with methanol at their home in Tokyo’s Ota Ward between Jan. 14 and 15 in 2022.
JAPAN / Crime & Legal
Sep 2, 2024
Ex-employee of Daiichi Sankyo denies poisoning his wife with methanol
Keisuke Yoshida, formerly a senior researcher at the pharmaceutical firm, said he had never thought of killing his wife.
Health minister Keizo Takemi fields questions from reporters in March after a Cabinet meeting to deal with health problems caused by Kobayashi Pharmaceutical's beni kōji red yeast rice supplements.
JAPAN / Science & Health
Aug 14, 2024
Health Minister Keizo Takemi on how to improve Japan's health care system
Digitalization, hiring high-skilled foreign workers and increasing wages are among the steps that Japan could take.
In the past 11 months, health minister Keizo Takemi has been charting his own path, seeking to make Japan's health care policies more global and digitalized.
JAPAN / Science & Health
Aug 14, 2024
Global mindset crucial for reform of Japan's health care, minister says
International strategies and domestic health care reform are inextricably linked, says health minister Keizo Takemi.
JAPAN / Science & Health
Nov 28, 2023
Japan approves first domestically developed COVID-19 XBB vaccine
The XBB-adapted coronavirus vaccine will be available as a booster under the nation’s free COVID-19 vaccination program beginning next week.
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
BUSINESS
Oct 20, 2023
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
JAPAN / Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN / Science & Health
Nov 15, 2022
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
BUSINESS / Companies
Sep 6, 2021
Daiichi Sankyo positions its COVID-19 vaccine as a booster in Japan
Daiichi Sankyo is aiming for full regulatory approval by the second half of next year.
Japan Times
JAPAN / Science & Health
Mar 23, 2021
Japanese firms launch domestic clinical trials for COVID-19 vaccines
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.
Trump pledges to save U.S. from 'decline,' vowing new 'golden age'
U.S. President Donald Trump signs executive orders in the Oval Office of the White House in Washington on Monday.
Cedar pollen is already in the air in Tokyo
Climate change and urbanization are believed to have contributed to the earliest ever observation of cedar pollen in Tokyo, on Jan. 8, an expert says.
What went wrong at Fuji TV's news conference on allegations against Nakai?
Fuji TV President Koichi Minato speaks at a news conference on Friday in Tokyo.
BOJ likely to raise rates this week in absence of immediate Trump tariffs
Bank of Japan Gov. Kazuo Ueda is still signaling caution ahead of the central bank's January meeting.
Survey finds 80% of people want to take leftover restaurant food home
52.0% of people questioned in a survey said they want to use containers to take leftovers home if they are provided free of charge, and 28.8% showed willingness to use takeout containers whether they are free or not.
'America first' returns as Trump ditches focus on allies and rules-based order
U.S. President Donald Trump reviews troops during his inauguration ceremony at the Capitol in Washington on Monday.
Japan looks to learn from the past with bid to build Australian warships
The Maritime Self-Defense Force's Mogami frigate, of the class of the same name, is anchored at the MSDF's naval base in the city of Yokosuka, Kanagawa Prefecture, in September 2022.
Amid rising world hunger, a Japan-inspired group in Kenya is making a big impact
Wawira Njiru, the founder of Food4Education, serves food during the opening of a new kitchen in Mombasa County, Kenya, in 2022. The organization started in 2012 by feeding 25 children out of a single kitchen. Now it feeds nearly half a million every day.
From Tokyo to Manhattan, Takuma Watanabe stirs up a stiff drink
It's taken Takuma Watanabe little time to establish himself as one of New York's hottest bartenders.
For tourists in search of seasonal sights, Yamagata makes its case
For some time away from Tokyo's suffocating urban sameness, Yamagata Prefecture is home to a soothing array of natural abundance.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Atsuyoshi Koike, the president and CEO of Rapidus, says there is a “sense of urgency” when it comes to Japan’s efforts in manufacturing semiconductors. “We have to make sure we are successful,” he says.
Atsuyoshi Koike’s big game: Fourth down and 2 nanometers to go
By Kazuaki Nagata and Richard Meyer

SUSTAINABLE JAPAN

SWCC keeps changing with keyword ‘new challenges’
SWCC keeps changing with keyword ‘new challenges’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER